IRBM
Trending Articles
Related Content
Research & Development
CHDI Foundation extends collaboration with IRBM to develop Huntington’s disease therapeutics
IRBM has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a non-profit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD)